NEW YORK ( TheStreet) -- Geron Corporation (Nasdaq: GERN) hit a new 52-week low Thursday as it is currently trading at $1.58, below its previous 52-week low of $1.59 with 841,713 shares traded as of 11:10 a.m. ET. Average volume has been 1.6 million shares over the past 30 days. Geron has a market cap of $230.1 million and is part of the health care sector and drugs industry. Shares are down 68.8% year to date as of the close of trading on Wednesday. Geron Corporation, a biopharmaceutical company, develops biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, and diabetes.
- Practice your GERN trading strategies and win cash in our stock game.